Migraines & headaches Board decisions

The Board denied service connection for migraine headaches as they are not proximately due to or the result of an already service-connected disease or injury, and there is no evidence establishing a causal relationship between the Veteran's migraines and his tinnitus.

The Board restored the 30 percent rating for migraines effective March 1, 2015, and denied a rating in excess of 30 percent. The Board also denied a rating in excess of 70 percent for PTSD with panic disorder.

The Board denied service connection for unspecified depressive disorder with anxious distress, back condition, headaches, bilateral hip condition, and erectile dysfunction. The Veteran was granted an earlier effective date of May 6, 2022, but no earlier, for an initial noncompensable rating for bilateral hearing loss.

The Board denied service connection for a left knee disability, an upper respiratory disability (to include sinusitis), and chronic headaches due to the lack of evidence linking these conditions to the Veteran's military service.

The Board dismissed the veteran's claims for service connection and earlier effective dates, as well as rating increases, due to procedural defects in the filing of his appeal.

The Board granted an initial rating of 30 percent for headaches and 10 percent for left and right hand tremors, but denied service connection for bilateral hearing loss.

The Board remands the claims for service connection for headaches, PTSD, and unspecified depressive disorder to correct pre-decisional duty to assist errors.

The Board granted a 10 percent rating for posttraumatic headaches as of April 22, 2024, but denied an initial compensable rating prior to that date.

The Board denied the veteran's claims for an initial compensable rating for dermatosis, allergic rhinitis, and service connection for bilateral hearing loss and headaches.

The Board granted service connection for peptic ulcer disease and pelvic congestion syndrome, and assigned initial ratings of 70%, 30%, 60%, 30%, 40%, and 10% for posttraumatic stress disorder (PTSD), gastroesophageal reflux disease (GERD), dermatitis, migraines, lumbosacral strain, and left lower extremity radiculopathy respectively. The Board remanded the claim of an initial rating in excess of 10 percent for costochondritis.

The Board restored the Veteran's hypothyroidism rating from 10 percent to 30 percent, as the reduction was not proper. The claims for an increased rating for migraines and TDIU were remanded.

The Board denied the veteran's claims for increased ratings and earlier effective dates, granted an earlier effective date for major depressive disorder, and remanded service connection for costochondritis.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several other claims.

The Board denied service connection for a right knee disability as there was no evidence of an injury during active duty, ACDUTRA, or INACDUTRA. The other claims were remanded to correct a duty to assist error.

The Board granted a 50 percent rating for migraines and a 30 percent rating for chronic urticaria, while denying a compensable rating for allergic rhinitis and service connection for frost bite residuals.

The appeal is remanded to the VA Regional Office for adjudication of a substitution request and readjudication of the claims.

The Board remands the claim for a headache disability to obtain an adequate medical opinion regarding whether it is proximately due to or aggravated by service-connected tinnitus.

The Board denied an initial disability rating greater than 70 percent for service-connected residuals of traumatic brain injury and remanded the claim for a separate disability rating for headache episode residuals of TBI.

The Board granted service connection for PTSD, major depressive disorder with anxious distress, general anxiety disorder, and unspecified trauma and stressor related disorder, but denied service connection for allergic rhinitis. The Board also granted a 20 percent initial disability rating for bilateral hearing loss from September 19, 2024, and denied higher ratings for tension headaches.

The Board granted an initial rating of 50 percent for tension and cluster headaches, a rating of 50 percent for carpal tunnel syndrome (CTS) and cervical radiculopathy of the right upper extremity effective May 7, 2024, and denied higher ratings for CTS and cervical radiculopathy of the right upper extremity.